Italy is moving towards value-based health care. New products that provide better health outcomes in cost-effective ways will be the preferred. The public healthcare system (which makes up 75% of the Italian market) is likely to develop value-based and quality-based pricing models, thereby requesting data and analytics from suppliers for cost-effectiveness assessments. Very innovative products are being increasingly compared to traditional products.
The main areas of demand in the Italian market include: devices for preventive care, remote monitoring and early identification of at-risk-patients.
